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Abstract 
Case report on a new case of acute lymphoblastic 
leukemia with der(X)t(X;8)(q28;q11.2). 
Clinics 
Age and sex: 19 year(s) old male patient 
Previous history: no preleukemia , no previous 
malignancy , no inborn condition of note  
Organomegaly: hepatomegaly ; splenomegaly ; 
enlarged lymph nodes (Few reddish skin nodules 5-
7 mm in diameter); central nervous system 
involvement (A tumor-forming mass located in 
temporal lobe of brain at post-transplant relapse.)  
Blood 
WBC: 1.7X 109/l 
HB: 9.0g/dl 
Platelets: 296X 109/l 
Bone marrow: Bone marrow smears showed 
hypercellular bone marrow with 54.4% blasts. They 
were negative for myeloperoxidase, whereas most of 
them positive for PAS stain. The cytoplasm of blasts 
was narrow and basophilic. Blasts had rounded 
nucleus and finely dispersed chromatin with well-
contoured nucleoli. Erythropoiesis and myelopoiesis 
were decreased. Erythropoiesis had signs of 
megaloblastosis. Megakaryocytopoiesis: 






Positive for CD34, CD10, CD19, CD20, CD38. 
Rearranged Ig Tcr : Not performed. 
Pathology : Histopathology of the skin nodules was 
remarkable for interstitially located groups of small- 
and middle-sized lymphoid blast-like cells, which 
were positive for TdT, PAX-5, CD20, CD10, 
negative for T-cell and myeloid markers and had a 
very high proliferation rate (Ki-67 index above 90 
%).  
C-myc oncogene product was additionally assessed 
with immunohistochemistry (clone Y69). Over 90% 
of blast cells in the skin appeared to be positive for 
?-myc, although staining pattern was markedly 
heterogeneous.  
The brain tissue (at post-transplant relapse) 
contained a dense cellular infiltrate composed of 
middle-sized PAS-positive blasts with oval or round 
nuclei, containing 2-3 small nucleoli. Tumor cells 
were uniformly positive for TdT, CD19, PAX-5, and 
CD79a and had a very high Ki-67 proliferation 
index. C-myc oncogene product was demonstrated 
in over 85% of cells with heterogeneous staining 
pattern, compatible with indirect c-myc up-
regulation. 
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Electron microscopy : Not performed. 
Diagnosis Common acute lymphoblastic leukemia 
Survival 
Date of diagnosis 09-2012 
Treatment: Treatment was started according to 
ALL-2009 protocol, containing Daunorubicin, 
VIncristine and L-asparaginase. CNS prophylaxis 
therapy consisted intrathecal treatment, whereas 
cranial irradiation was not used. 
Complete remission: obtained   
Treatment related death: no 
Relapse: Yes. Complex medullar and CNS 
extramedullary relapses were diagnosed repeatedly 
on 10 and 13 months after remission.  
The patient received allogeneic HSCT on 04/2014. 
Complete remission was achieved on 06/2014. 
Isolated post-transplant CNS relapse was diagnosed 
on 11/2014. 
Phenotype at relapse : Positive for CD34, CD10, 
CD19, CD20, CD38. 
Status: Dead  
Survival: 29 months 
Karyotype 
Sample Bone marrow aspirate, brain tumor mass (by 
stereotactic brain biopsy at post-transplant relapse) 
Culture time 24 h, without stimulating agents. 
Banding GTG 
Results 45,Y,der(X)t(X;8)(q28;q11.2)[20] 
Karyotype at relapse  
45,Y,der(X)t(X;8)(q28;q11.2)[20] 
Other molecular cytogenetics technics 
Fluorescence in situ hybridisation (FISH) with 
whole painting probes for 8 and X chromosomes 
(Metasystems, Germany). Multicolor banding, using 




Other molecular cytogenetics results  
The unbalanced translocation 
der(X)t(X;8)(q28;q11.2) was revealed in all 
metaphases. 
Other molecular studies 
Technics RT-PCR 
Results  Leukemic cells were negative for 
t(1;19)E2A-PBX1, del(1)SIL-TAL1, t(12;21) TEL-
AML1, and t(9;22) BCR-ABL. 
Comments 
Here we report a new case of ALL with extremely 
rare abnormality der(X)t(X;8)(q28;q11.2), which 
resulted in a partial 8q trisomy. At the first time a 
case with der(X)t(X;8)(q28;q11.2) was reported in a 
4-year-old child with Ph-positive ALL who has not 
achieved complete continuous remission [Kaleem et 
al, 2000].  
This patient had other recurrent chromosomal 
abnormalities, such as t(8;14)(q11.2;q32), 
t(9;22)(q34;q11) and add(17)(p13). It allows to 
consider, that the der(X)t(X;8) might be a secondary 
genetic event. As for our finding is concerned, it 
seems to be primary event, which is responsible for 
post-transplant isolated CNS relapse. 
Identical chromosome abnormalities in leukemic 
cells at diagnosis and in the cells from brain tumor-
forming relapse support the origin of both from 
common leukemic clone. c-Myc is one of the genes 
located on 8q which may be implicated in disease 
biology. Immunohistochemical staining for c-myc 
protein showed positivity of >85% of leukemic cells 
(at disease onset and at relapse), although with 
markedly heterogeneous staining pattern, 
compatible with indirect c-myc up-regulation. The 
latter, in turn, could increase proliferative potential 
of leukemic cells as well as their resistance to 
chemotherapy. Finally, trisomy 8 in ALL patients is 
considered to be indicative of poor prognosis 
[Garipidou et al, 1990]. 
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Figure 1: Histopathological findings in tumor-forming ALL relapse in the brain. Neoplastic cells with lymphoblastic morphology 
form diffuse dense infiltrate in the brain tissue (A), they are uniformly positive for TdT (B), CD19 (C), and heterogeneously 
express c-myc (D). Hematoxylin and eosin staining, 400× original magnification (A); IHC for TdT, 400? original magnification (B); 
IHC for CD19, 200× original magnification (C); IHC for c-myc 400× original magnification (D). 
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Figure 2: GTG-banded karyotype showing the derivative der(X)t(X;8)(q28;q11.2) 
Figure 3: GTG-banding showing the derivative X chromosome; FISH with whole painting probes showing two normal 
chromosomes 8 (green color) and the derivative der(X)t(X;8) (red and green colors). Multicolor banding of two normal 
chromosomes 8 and the derivative X chromosome. 
References 
Garipidou V, Ysamada T, Grant Prentice HTrisomy 8 in 
acute lymphoblastic leukemia (ALL): A case report and 
update of the literature. Leukemia. 1990;4:717-9 
Kaleem Z, Shuster JJ, Borowitz MJ. Acute lymphoblastic 
leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric 
Oncology Group study. Leukemia. 2000;14:238-240 
This article should be referenced as such: 
Gindina T, Mamayev N, Baykov V, Slesarchuk O, 
Rudakova T, Babenko E, Afanasyev B. A new case of 
acute lymphoblastic leukemia with 
der(X)t(X;8)(q28;q11.2). Atlas Genet Cytogenet Oncol 
Haematol. 2017; 21(11):434-437. 
